Physician profile
Steven R Luttrell
NPI 1174567713
$712.72
in general payments reported to CMS, 2019-2025
12 companies · $171 in 2025
The $171 reported for 2025 was more than what 86% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $75.58 · 2023: $103 · 2024: $208 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $192.87 | 2022-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $111.81 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $83.54 | 2024-2025 | Entyvio |
| Abbvie INC. | $72.01 | 2022-2024 | |
| Edwards Lifesciences Corporation | $54.20 | 2024 | Hemosphere |
| Ardelyx, INC. | $51.98 | 2024 | Ibsrela |
| Acacia Pharma INC | $43.32 | 2021 | |
| Heron Therapeutics, INC. | $24.88 | 2025 | Aponvie |
| Janssen Biotech, INC. | $21.11 | 2025 | Tremfya |
| Octapharma USA, INC. | $20.56 | 2025 | Fibryga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.40 | 2024 | Xifaxan |
| Avanos Medical | $18.04 | 2023 | On-Q* Pump and Accessories |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Luttrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.